Oak Family Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-46,590
Closed -$4.19M 132
2025
Q4
$4.19M Sell
46,590
-37,733
-45% -$3.58M 1.15% 31
2025
Q3
$8.31M Sell
84,323
-16,035
-16% -$1.59M 2.08% 12
2025
Q2
$9.15M Buy
100,358
+19,714
+24% +$1.91M 2.89% 9
2025
Q1
$9.13M Buy
80,644
+14,209
+21% +$1.52M 3.07% 7
2024
Q4
$7.02M Buy
66,435
+1,357
+2% +$146K 2.54% 12
2024
Q3
$7.03M Sell
65,078
-1,218
-2% -$133K 2.16% 10
2024
Q2
$7.2M Buy
66,296
+1,821
+3% +$215K 2.47% 11
2024
Q1
$8.51M Sell
64,475
-156
-0.2% -$19.5K 3.27% 5
2023
Q4
$7.87M Buy
+64,631
New +$7.21M 3.31% 4

Other funds holding ZBH

Oak Family Advisors's ZBH Position: Q1 2026 in Review

Oak Family Advisors sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 46,590 shares — an estimated $4.19M sold.

Oak Family Advisors first reported a position in ZBH in Q4 2023 and held it in 9 quarters. The position peaked at $9.15M in Q2 2025. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Oak Family Advisors reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Oak Family Advisors sold 46,590 Zimmer Biomet shares in Q1 2026, an estimated $4.19M.
  • Oak Family Advisors first reported a position in Zimmer Biomet in Q4 2023 and held it in 9 quarters.
  • Oak Family Advisors's Zimmer Biomet position peaked at $9.15M in Q2 2025.
  • 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Oak Family Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.